Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Richard Gregg currently holds 228,274 shares of Vitae Pharmaceuticals, Inc (VTAE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Richard Gregg has been a net neutral trader of VTAE stock. They have purchased $0 and sold $0 worth of shares.
Richard Gregg's most recent insider trade was on Oct 25, 2016, when they sold 228,274 shares at $21.00 per share.
Richard Gregg serves as Executive at Vitae Pharmaceuticals, Inc (VTAE). They have executed 10 insider transactions totaling $0 over their tenure at the company.
Richard Gregg holds the position of Executive at Vitae Pharmaceuticals, Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Richard Gregg has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Richard Gregg was on Oct 25, 2016, when they sold $4.8M worth of VTAE shares. This transaction involved 228,274 shares at $21.00 per share.
Richard Gregg currently owns 228,274 shares of Vitae Pharmaceuticals, Inc (VTAE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Richard Gregg's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Richard Gregg has 10 Form 4 filings on record as an insider at Vitae Pharmaceuticals, Inc.
Set alerts for Richard Gregg and 40,000+ other insiders.